{"apiVersion":"2.155","reference":"50217321TOPICSen","url":"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-CL3-2026-01-FCT-06","contentType":"text/plain","language":"en","databaseLabel":"SEDIA","database":"SEDIA","summary":"Prevention and mitigation of misuse of synthetic biology for bioterrorism purposes","weight":1.0,"groupById":"1","content":"Prevention and mitigation of misuse of synthetic biology for bioterrorism purposes","accessRestriction":false,"checksum":"F3CD7A0E68A91ED58845A04038BEE3DA0CA978F0BBCCF5BBA777636AF3A6C9D9","metadata":{"latestInfos":["[{\"approvalDate\":\"\",\"lastChangeDate\":\"2026-05-07T08:46:04.536\",\"content\":\"The submission session is now available for: HORIZON-CL3-2026-01-DRS-04, HORIZON-CL3-2026-01-BM-01, HORIZON-CL3-2026-01-DRS-01, HORIZON-CL3-2026-01-FCT-02, HORIZON-CL3-2026-01-BM-03, HORIZON-CL3-2026-01-FCT-05, HORIZON-CL3-2026-01-BM-02, HORIZON-CL3-2026-01-FCT-03, HORIZON-CL3-2026-01-FCT-04, HORIZON-CL3-2026-01-SSRI-01, HORIZON-CL3-2026-01-DRS-05, HORIZON-CL3-2026-01-INFRA-03, HORIZON-CL3-2026-01-DRS-03, HORIZON-CL3-2026-01-DRS-02, HORIZON-CL3-2026-01-SSRI-04, HORIZON-CL3-2026-01-INFRA-01, HORIZON-CL3-2026-01-FCT-01, HORIZON-CL3-2026-01-SSRI-02, HORIZON-CL3-2026-01-FCT-06, HORIZON-CL3-2026-01-SSRI-03, HORIZON-CL3-2026-01-INFRA-02\"}]"],"es_SortDate":["2026-05-06T00:00:00.000+0000"],"sepTemplate":["<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p><p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>"],"keywords":["HORIZON-CL3-2026-01-FCT-06","HORIZON-CL3-2026-01","Biotechnology","Fight against crime and terrorism","Security","Synthetic biology, chemical biology and new bio-engineering concepts"],"sortStatus":["1"],"language":["en"],"topicConditions":["<div class=\"eui-u-mt-l>\"><h4>General conditions</h4><div><h4>1. Admissibility Conditions: Proposal page limit and layout</h4><div class=\"eui-u-mt-s\"><p>described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex A</a> and <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex E</a> of the Horizon Europe Work Programme General Annexes.</p><p><strong>Proposal page limits and layout:</strong> described in Part B of the Application Form available in the Submission System.</p></div></div><div><h4>2. Eligible Countries</h4><div class=\"eui-u-mt-s\"><p>described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex B</a> of the Work Programme General Annexes.</p><p>A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Horizon Europe Programme Guide</a>.</p></div></div><div><h4>3. Other Eligible Conditions</h4><div class=\"eui-u-mt-s\"><p>If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).</p></div><div class=\"eui-u-mt-s\"><p>described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex B</a> of the Work Programme General Annexes.</p></div></div><div><h4>4. Financial and operational capacity and exclusion</h4><div class=\"eui-u-mt-s\"><p>described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex C</a> of the Work Programme General Annexes.</p></div></div><div><h4>5a. Evaluation and award: Award criteria, scoring and thresholds</h4><div class=\"eui-u-mt-s\"><p>are described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex D</a> of the Work Programme General Annexes.</p></div></div><div><h4>5b. Evaluation and award: Submission and evaluation processes</h4><div class=\"eui-u-mt-s\"><p>are described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex F</a> of the Work Programme General Annexes and the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Online Manual</a>.</p></div></div><div><h4>5c. Evaluation and award: Indicative timeline for evaluation and grant agreement</h4><div class=\"eui-u-mt-s\"><p>described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex F</a> of the Work Programme General Annexes.</p></div></div><div><h4>6. Legal and financial set-up of the grants</h4><div class=\"eui-u-mt-s\"><p>The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.</p></div><div class=\"eui-u-mt-s\"><p>Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf\"><u>decision</u></a> is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf\"><u>https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf</u></a>]].</p></div><div class=\"eui-u-mt-s\"><p>described in <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Annex G</a> of the Work Programme General Annexes.</p></div></div></div><div class=\"eui-u-mt-l\"><h4>Specific conditions</h4> <div class=\"eui-u-mt-s\"><p>described in the [specific topic of the Work Programme]</p></div></div><div class=\"eui-u-mt-s\"><p>Some activities resulting from this topic may involve using classified background and/or producing of security sensitive results (EUCI and SEN). Please refer to the related provisions in section B Security — EU classified and sensitive information of the General Annexes.</p></div><div class=\"eui-u-mt-l\"><div class=\"eui-u-mt-s\">\n</div><h4>Application and evaluation forms and model grant agreement (MGA):</h4> <div class=\"eui-u-mt-s\"><p><strong>Application form templates</strong> <em>— the application form specific to this call is available in the Submission System</em></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/af_he-ria-ia_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Standard application form (HE RIA, IA)</a></p><p><strong>Evaluation form templates</strong> <em>— will be used with the necessary adaptations</em> </p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/ef/ef_he-ria-ia_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Standard evaluation form (HE RIA, IA)</a> </p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">HE Programme Guide</a> </p><p><strong>Model Grant Agreements (MGA)</strong></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/ls-mga_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Lump Sum MGA</a> </p><p><strong>Call-specific instructions</strong> </p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/temp-form/af/detailed-budget-table_he-ls-euratom_en.xlsm\" rel=\"noopener noreferrer\" target=\"_blank\">Detailed budget table (HE LS)</a> </p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-financial-support-to-third-parties_he_en.docx\" rel=\"noopener noreferrer\" target=\"_blank\">Information on financial support to third parties (HE)</a> </p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-funding-what-do-i-need-to-know_he_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Guidance: \"Lump sums - what do I need to know?\"</a></p></div><h4>Additional documents:</h4> <div class=\"eui-u-mt-s\"><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-1-general-introduction_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">HE Main Work Programme 2026-2027 – 1. General Introduction</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-6-civil-security-for-society_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">HE Main Work Programme 2026-2027 – 6. Civil Security for Society</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2026-2027/wp-15-general-annexes_horizon-2026-2027_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">HE Main Work Programme 2026-2027 – 15. General Annexes</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">HE Programme Guide</a></p><p><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0695\" rel=\"noopener noreferrer\" target=\"_blank\">HE Framework Programme 2021/695</a></p><p><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021D0764\" rel=\"noopener noreferrer\" target=\"_blank\">HE Specific Programme Decision 2021/764</a></p><p><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=OJ:L_202402509\" rel=\"noopener noreferrer\" target=\"_blank\">EU Financial Regulation 2024/2509</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Decision authorising the use of lump sum contributions under the Horizon Europe Programme</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/rules-lev-lear-fca_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment</a></p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/aga_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">EU Grants AGA — Annotated Model Grant Agreement</a> </p><p><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\" rel=\"noopener noreferrer\" target=\"_blank\">Funding &amp; Tenders Portal Online Manual</a> </p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/tc_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Funding &amp; Tenders Portal Terms and Conditions</a> </p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/legalnotice\" rel=\"noopener noreferrer\" target=\"_blank\">Funding &amp; Tenders Portal Privacy Statement</a></p></div></div>"],"title":["Prevention and mitigation of misuse of synthetic biology for bioterrorism purposes"],"type":["1"],"esST_checksum":["F3CD7A0E68A91ED58845A04038BEE3DA0CA978F0BBCCF5BBA777636AF3A6C9D9"],"focusArea":[],"esST_FileName":["file.txt"],"typeOfMGAs":["43027849"],"callIdentifier":["HORIZON-CL3-2026-01"],"ccm2Id":["50217321"],"callccm2Id":["50217687"],"DATASOURCE":["SEDIA"],"REFERENCE":["50217321TOPICSen"],"links":["[{\"callIdentifier\":\"HORIZON-CL3-2026-01\",\"criterionCode\":\"HORIZON-RIA\",\"criterionDescription\":\"HORIZON  Research and Innovation Actions\",\"url\":\"https://ec.europa.eu/research/participants/submission/manage/screen/submission/create-draft/43991?topic\\u003dHORIZON-CL3-2026-01-FCT-06\",\"startDate\":\"1778025600000\",\"endDate\":\"1793836800000\",\"mgaDescription\":\"HORIZON Lump Sum Grant\",\"mgaCode\":\"HORIZON-AG-LS\"}]"],"callTitle":["Civil Security for Society 2026"],"frameworkProgramme":["43108390"],"descriptionByte":["<p class=\"topicdescriptionkind\">Expected Outcome:</p><p>Project results are expected to contribute to <strong>all</strong> of the following expected outcomes:</p><ul level=\"0\"><li>Increased understanding of European policy makers, research community, biotech companies, and relevant security practitioners of the threat of bioterrorism and of synthetic biology, including a thorough lawful analysis of what needs to be monitored in this context, what needs to be regulated and how;</li><li>Awareness raised within the related scientific community how research in synthetic biology can be used for malicious purposes. </li> </ul><p class=\"topicdescriptionkind\">Scope:</p><p>The rising threat of bioterrorism is driven by recent scientific advancements, notably by growing accessibility of synthetic biology, genetic engineering, related commercial services and public databases, which in turn enhance their obtainability to non-state actors and individuals with malicious intentions. The proliferation of do-it-yourself biohacking and community laboratories, including gene editing and sequencing technology, dropping costs of equipment and increased simplicity of use may inadvertently facilitate knowledge and skills dissemination about biological threats and open new pathways for bioterrorism. Challenges in detection, particularly the lengthy incubation periods of biological agents, underscore the urgent need for improved identification technologies to allow for timely intervention and reduce potential mass casualties, considering both characterization through advanced tools by expert labs and simple deployable methods. Given that properly weaponized biological agents can be more lethal than nuclear weapons, their cross-border implications warrant focused attention. Recent incidents involving biotoxins across various European countries illustrate the feasibility of biological attacks. The increasing weaponisation of drones highlights an alarming trend that could extend to biological agents, further complicating threat landscapes. The potential economic and social consequences of biological attacks necessitate robust prevention and preparedness measures to mitigate overwhelming impacts on healthcare systems and society at large.</p><p>Proposals are expected to address, in a lawful manner, the emerging threats of bioterrorism in Europe, particularly in the context of synthetic biology. Recognising bioterrorism as a low-probability but high-impact event, consortia should review current and future risks, flag areas requiring reinforced monitoring, as well as identify missing regulatory frameworks necessary for ensuring public security and safety. Furthermore, proposals should bring together diverse consortia to enhance our understanding, prevention, preparedness, and response to bioterrorism and create a comprehensive approach to this pressing issue.</p><p>Coordination among the successful proposals from this topic should be envisaged to avoid duplication and to exploit complementarities as well as opportunities for increased impact. In this topic the integration of the gender dimension (sex and gender analysis) in research and innovation content should be addressed only if relevant in relation to the objectives of the research effort.</p><p>Proposals funded under this topic are expected to provide ideas on how they would engage with the Europol Innovation Lab during the lifetime of the project. Similarly, if the proposals concern drug-related issues, they are expected to engage with the EU Drugs Agency during the lifetime of the project, including validating the outcomes.</p><p>Finally, proposals are expected to address all applicable considerations expressed in the Introduction of the Fighting Crime and Terrorism Destination.</p><p class=\"topicdescriptionkind\">Technology Readiness Level - Technology readiness level expected from completed projects</p><div class=\"eui-u-mt-s\"><p>Activities are expected to achieve TRL 4-5 by the end of the project – see General Annex B.</p></div>"],"identifier":["HORIZON-CL3-2026-01-FCT-06"],"es_ContentType":["text/plain"],"programmeDivision":["43108390","43108541","43118971","43120180"],"crossCuttingPriorities":["AI","DigitalAgenda"],"esDA_FirstIngestDate":["2025-12-16T15:10:58.701+0100"],"programmePeriod":["2021 - 2027"],"deadlineDate":["2026-11-05T00:00:00.000+0000"],"esDA_IngestDate":["2026-09-03T11:00:45.087+0200"],"typesOfAction":["HORIZON  Research and Innovation Actions"],"url":["https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-CL3-2026-01-FCT-06"],"es_Combine":["1"],"esST_URL":["https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-CL3-2026-01-FCT-06"],"tags":["biotech","bioterrorism","crime","mitigation","research","security practitioners","synthetic biology"],"cenTagsA":["TOPICS-045609","TOPICS-045610","TOPICS-045611","TOPICS-045612","TOPICS-045613","TOPICS-045614","TOPICS-001588","TOPICS-019524","TOPICS-006651","TOPICS-045615","TOPICS-017740","TOPICS-009251","TOPICS-001241","TOPICS-000174","TOPICS-020051","TOPICS-008403","TOPICS-006090"],"esDA_QueueDate":["2026-09-03T11:00:45.079+0200"],"actions":["[{\"types\":[{\"typeOfAction\":\"HORIZON-RIA HORIZON  Research and Innovation Actions\",\"typeOfMGA\":[{\"id\":43027849,\"abbreviation\":\"HORIZON-AG-LS\",\"description\":\"HORIZON Lump Sum Grant\"}]}],\"status\":{\"id\":31094502,\"abbreviation\":\"Open\",\"description\":\"Open\"},\"plannedOpeningDate\":\"2026-05-06\",\"submissionProcedure\":{\"id\":31094504,\"abbreviation\":\"single-stage\",\"description\":\"single-stage\"},\"deadlineDates\":[\"2026-11-05\"]}]"],"allowPartnerSearch":["true"],"budgetOverview":["{\"budgetYearsColumns\":[\"2026\"],\"budgetTopicActionMap\":{\"113345\":[{\"action\":\"HORIZON-CL3-2026-01-BM-03 - HORIZON-CSA HORIZON Coordination and Support Actions\",\"expectedGrants\":1,\"minContribution\":1330000,\"maxContribution\":1330000,\"budgetYearMap\":{\"2026\":\"1330000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113344\":[{\"action\":\"HORIZON-CL3-2026-01-FCT-02 - HORIZON-RIA HORIZON  Research and Innovation Actions\",\"expectedGrants\":2,\"minContribution\":4500000,\"maxContribution\":4500000,\"budgetYearMap\":{\"2026\":\"9000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113347\":[{\"action\":\"HORIZON-CL3-2026-01-BM-02 - HORIZON-IA HORIZON Innovation Actions\",\"expectedGrants\":2,\"minContribution\":4000000,\"maxContribution\":4000000,\"budgetYearMap\":{\"2026\":\"8000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113346\":[{\"action\":\"HORIZON-CL3-2026-01-FCT-05 - HORIZON-IA HORIZON Innovation Actions\",\"expectedGrants\":2,\"minContribution\":4835000,\"maxContribution\":4835000,\"budgetYearMap\":{\"2026\":\"9670000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113349\":[{\"action\":\"HORIZON-CL3-2026-01-FCT-04 - HORIZON-RIA HORIZON  Research and Innovation Actions\",\"expectedGrants\":2,\"minContribution\":3000000,\"maxContribution\":3000000,\"budgetYearMap\":{\"2026\":\"6000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113348\":[{\"action\":\"HORIZON-CL3-2026-01-FCT-03 - HORIZON-IA HORIZON Innovation Actions\",\"expectedGrants\":1,\"minContribution\":5000000,\"maxContribution\":5000000,\"budgetYearMap\":{\"2026\":\"5000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113351\":[{\"action\":\"HORIZON-CL3-2026-01-DRS-05 - HORIZON-IA HORIZON Innovation Actions\",\"expectedGrants\":1,\"minContribution\":4500000,\"maxContribution\":4500000,\"budgetYearMap\":{\"2026\":\"4500000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113350\":[{\"action\":\"HORIZON-CL3-2026-01-SSRI-01 - HORIZON-RIA HORIZON  Research and Innovation Actions\",\"expectedGrants\":2,\"minContribution\":1500000,\"maxContribution\":1500000,\"budgetYearMap\":{\"2026\":\"3000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113353\":[{\"action\":\"HORIZON-CL3-2026-01-DRS-03 - HORIZON-IA HORIZON Innovation Actions\",\"expectedGrants\":2,\"minContribution\":4000000,\"maxContribution\":4000000,\"budgetYearMap\":{\"2026\":\"8000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113352\":[{\"action\":\"HORIZON-CL3-2026-01-INFRA-03 - HORIZON-IA HORIZON Innovation Actions\",\"expectedGrants\":2,\"minContribution\":4500000,\"maxContribution\":4500000,\"budgetYearMap\":{\"2026\":\"9000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113355\":[{\"action\":\"HORIZON-CL3-2026-01-SSRI-04 - HORIZON-IA HORIZON Innovation Actions\",\"expectedGrants\":1,\"minContribution\":3000000,\"maxContribution\":3000000,\"budgetYearMap\":{\"2026\":\"3000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113354\":[{\"action\":\"HORIZON-CL3-2026-01-DRS-02 - HORIZON-IA HORIZON Innovation Actions\",\"expectedGrants\":2,\"minContribution\":4000000,\"maxContribution\":4000000,\"budgetYearMap\":{\"2026\":\"8000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113357\":[{\"action\":\"HORIZON-CL3-2026-01-FCT-01 - HORIZON-RIA HORIZON  Research and Innovation Actions\",\"expectedGrants\":2,\"minContribution\":4000000,\"maxContribution\":4000000,\"budgetYearMap\":{\"2026\":\"8000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113356\":[{\"action\":\"HORIZON-CL3-2026-01-INFRA-01 - HORIZON-IA HORIZON Innovation Actions\",\"expectedGrants\":2,\"minContribution\":4835000,\"maxContribution\":4835000,\"budgetYearMap\":{\"2026\":\"9670000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113359\":[{\"action\":\"HORIZON-CL3-2026-01-FCT-06 - HORIZON-RIA HORIZON  Research and Innovation Actions\",\"expectedGrants\":1,\"minContribution\":3000000,\"maxContribution\":3000000,\"budgetYearMap\":{\"2026\":\"3000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113358\":[{\"action\":\"HORIZON-CL3-2026-01-SSRI-02 - HORIZON-PCP HORIZON Pre-commercial Procurement\",\"expectedGrants\":1,\"minContribution\":5830000,\"maxContribution\":5830000,\"budgetYearMap\":{\"2026\":\"5830000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113361\":[{\"action\":\"HORIZON-CL3-2026-01-INFRA-02 - HORIZON-RIA HORIZON  Research and Innovation Actions\",\"expectedGrants\":1,\"minContribution\":4000000,\"maxContribution\":4000000,\"budgetYearMap\":{\"2026\":\"4000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113360\":[{\"action\":\"HORIZON-CL3-2026-01-SSRI-03 - HORIZON-PPI HORIZON Public Procurement of Innovative Solutions\",\"expectedGrants\":1,\"minContribution\":2000000,\"maxContribution\":2000000,\"budgetYearMap\":{\"2026\":\"2000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113341\":[{\"action\":\"HORIZON-CL3-2026-01-BM-01 - HORIZON-IA HORIZON Innovation Actions\",\"expectedGrants\":2,\"minContribution\":6000000,\"maxContribution\":6000000,\"budgetYearMap\":{\"2026\":\"12000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113343\":[{\"action\":\"HORIZON-CL3-2026-01-DRS-01 - HORIZON-RIA HORIZON  Research and Innovation Actions\",\"expectedGrants\":2,\"minContribution\":3000000,\"maxContribution\":3000000,\"budgetYearMap\":{\"2026\":\"6000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}],\"113342\":[{\"action\":\"HORIZON-CL3-2026-01-DRS-04 - HORIZON-IA HORIZON Innovation Actions\",\"expectedGrants\":2,\"minContribution\":3000000,\"maxContribution\":3000000,\"budgetYearMap\":{\"2026\":\"6000000\"},\"plannedOpeningDate\":\"2026-05-06\",\"deadlineModel\":\"single-stage\",\"deadlineDates\":[\"2026-11-05\"]}]}}"],"startDate":["2026-05-06T00:00:00.000+0000"],"deadlineModel":["single-stage"],"specificObjective":[],"supportInfo":["<p><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\" rel=\"noopener noreferrer\" target=\"_blank\">Online Manual</a> is your guide on the procedures from proposal submission to managing your grant.</p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">Horizon Europe Programme Guide</a> contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.</p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq?isExactMatch=true&amp;status=0&amp;type=0,1&amp;order=DESC&amp;pageNumber=1&amp;pageSize=50&amp;sortBy=publicationDate\" rel=\"noopener noreferrer\" target=\"_blank\">Funding &amp; Tenders Portal FAQ</a> – find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.</p><p><a href=\"https://research-and-innovation.ec.europa.eu/contact-us/research-enquiry-service_en\" rel=\"noopener noreferrer\" target=\"_blank\">Research Enquiry Service</a> – ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.</p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/ncp\" rel=\"noopener noreferrer\" target=\"_blank\">National Contact Points (NCPs)</a> – get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (‘third-countries’).</p><p><a href=\"https://een.ec.europa.eu/\" rel=\"noopener noreferrer\" target=\"_blank\">Enterprise Europe Network</a> – contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.</p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" rel=\"noopener noreferrer\" target=\"_blank\">IT Helpdesk</a> – contact the Funding &amp; Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.</p><p><a href=\"https://intellectual-property-helpdesk.ec.europa.eu/index_en\" rel=\"noopener noreferrer\" target=\"_blank\">European IPR Helpdesk</a> assists you on intellectual property issues.</p><p><a href=\"mailto:research@cencenelec.eu\" rel=\"noopener noreferrer\" target=\"_blank\">CEN-CENELEC Research Helpdesk</a> and <a href=\"https://www.etsi.org/research/helpdesk\" rel=\"noopener noreferrer\" target=\"_blank\">ETSI Research Helpdesk</a> – the European Standards Organisations advise you how to tackle standardisation in your project proposal.</p><p><a href=\"https://euraxess.ec.europa.eu/sites/default/files/am509774cee_en_e4.pdf\" rel=\"noopener noreferrer\" target=\"_blank\">The European Charter for Researchers and the Code of Conduct for their recruitment</a> – consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.</p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/partner-search?order=DESC&amp;pageNumber=1&amp;pageSize=50&amp;sortBy=lastModified&amp;isExactMatch=true&amp;type=ORGANISATION,PERSON&amp;frameworkProgramme=43108390\" rel=\"noopener noreferrer\" target=\"_blank\">Partner Search</a> help you find a partner organisation for your proposal.</p>"],"status":["31094502"]},"enrichedMetadata":{},"children":[],"highlightedFragments":[],"citation":"Prevention and mitigation of misuse of synthetic biology for bioterrorism purposes. Available at: https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-CL3-2026-01-FCT-06"}